Unregulated Sales Of Combination Antibiotics In India Could Be Contributing To Drug Resistance, Reuters Reports
Reuters: Special Report: U.S. pharma giant profits as combination drugs flood India
“…Under India’s complex drug-approval regime, many pharmaceutical manufacturers have obtained permission from a single state to make new fixed-dose combination drugs, or FDCs, … and are selling them in other parts of the country without the approval of the central government. FDCs combine two or more drugs in a single pill. … Doctors and public health experts both in India and abroad say the proliferation and misuse of antibiotic combinations here may be contributing to antibiotic resistance, making India a potent incubator of so-called superbugs…” (Mahr et al., 12/15).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.